Distinct outcomes in patients with different molecular subtypes of inflammatory breast cancer.
Department of Breast Surgery, Xiangya Hospital, Central South University, Changsha, Hunan, China. E-mail. [email protected]
- Published Article
Saudi medical journal
- Publication Date
Nov 01, 2014
Breast cancer subtypes are associated with distinct outcomes in IBC patients. Patients that presented with triple negative IBC had poorer outcome than luminal A, luminal B, and HER-2 subtypes. These results indicate that IBC is a heterogeneous disease similar to the conventional breast cancer.
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
This record was last updated on 01/13/2018 and may not reflect the most current and accurate biomedical/scientific data available from NLM.
The corresponding record at NLM can be accessed at https://www.ncbi.nlm.nih.gov/pubmed/25399208